# EGRIFTA
> **BLA022505** · Biologics License Application · Sponsor: THERATECHNOLOGIES · Approved 2010-11-10
## Drug
- **FDA Application Number:** BLA022505
- **Application type:** Biologics License Application
- **Brand name:** EGRIFTA
- **Generic name:** TESAMORELIN
- **Active ingredients:** TESAMORELIN ACETATE
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** THERATECHNOLOGIES
- **Manufacturer:** Theratechnologies Inc.
- **First approval:** 2010-11-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022505)
---
*AI Analytics · CC0 1.0*